| Name | Lenscrafters #581 |
|---|---|
| Organization Name | Luxottica Of America Inc |
| Location | 304 N Garden, Bloomington, Minnesota 55425 |
| Type | Eyewear Supplier (Equipment, not the service) |
| Phone | (952) 858-9410 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Through the HBP, federal agencies fund a system of web-based databases and research tools that help brain scientists share and integrate their raw, primary research data. At the conference, eminent neuroscientists and neuroinformatics specialists will recap the field's achievements and forecast its future technological, scientific and social challenges and opportunities.
Neuralstem, Inc. announced that it has filed an Investigational New Drug (IND) application with the United States Food and Drug Administration (FDA) to begin two Phase I safety trials to test NSI-189, its first small molecule compound, for the treatment of major depression. NSI-189 is a proprietary new chemical entity discovered by Neuralstem that stimulates new neuron growth in the hippocampus, an area of the brain that is believed to be involved in depression.
Only 1 in 20 U.S. adolescents is meeting national recommendations for sleeping, physical activity, and screen time, according to new research by The University of Texas Health Science Center at Houston.
A new Texas Policy Evaluation Project study shows that use of medication abortion, also known as "the abortion pill," bounced back in Texas after a March 2016 label change by the US Food and Drug Administration.
Patients surviving childhood Hodgkin disease suffer strokes later in life at rates about four times that of the general population, UT Southwestern Medical Center researchers have found.
› Verified 2 days ago
| NPI Number | 1225184070 |
| Organization Name | LUXOTTICA OF AMERICA INC. |
| Doing Business As | LENSCRAFTERS #581 |
| Type | Eyewear Supplier (Equipment, not the service) |
| Address | 304 N Garden, Bloomington, MN 55425 |
| Phone Number | 952-858-8410 |
News Archive
Through the HBP, federal agencies fund a system of web-based databases and research tools that help brain scientists share and integrate their raw, primary research data. At the conference, eminent neuroscientists and neuroinformatics specialists will recap the field's achievements and forecast its future technological, scientific and social challenges and opportunities.
Neuralstem, Inc. announced that it has filed an Investigational New Drug (IND) application with the United States Food and Drug Administration (FDA) to begin two Phase I safety trials to test NSI-189, its first small molecule compound, for the treatment of major depression. NSI-189 is a proprietary new chemical entity discovered by Neuralstem that stimulates new neuron growth in the hippocampus, an area of the brain that is believed to be involved in depression.
Only 1 in 20 U.S. adolescents is meeting national recommendations for sleeping, physical activity, and screen time, according to new research by The University of Texas Health Science Center at Houston.
A new Texas Policy Evaluation Project study shows that use of medication abortion, also known as "the abortion pill," bounced back in Texas after a March 2016 label change by the US Food and Drug Administration.
Patients surviving childhood Hodgkin disease suffer strokes later in life at rates about four times that of the general population, UT Southwestern Medical Center researchers have found.
› Verified 2 days ago
News Archive
Through the HBP, federal agencies fund a system of web-based databases and research tools that help brain scientists share and integrate their raw, primary research data. At the conference, eminent neuroscientists and neuroinformatics specialists will recap the field's achievements and forecast its future technological, scientific and social challenges and opportunities.
Neuralstem, Inc. announced that it has filed an Investigational New Drug (IND) application with the United States Food and Drug Administration (FDA) to begin two Phase I safety trials to test NSI-189, its first small molecule compound, for the treatment of major depression. NSI-189 is a proprietary new chemical entity discovered by Neuralstem that stimulates new neuron growth in the hippocampus, an area of the brain that is believed to be involved in depression.
Only 1 in 20 U.S. adolescents is meeting national recommendations for sleeping, physical activity, and screen time, according to new research by The University of Texas Health Science Center at Houston.
A new Texas Policy Evaluation Project study shows that use of medication abortion, also known as "the abortion pill," bounced back in Texas after a March 2016 label change by the US Food and Drug Administration.
Patients surviving childhood Hodgkin disease suffer strokes later in life at rates about four times that of the general population, UT Southwestern Medical Center researchers have found.
› Verified 2 days ago
Cvs Pharmacy #03060 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 8936 Lyndale Ave S, Bloomington, Minnesota 55420 Phone: (952) 881-0163 | |
Cvs Pharmacy #16002 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2555 W 79th St, Bloomington, Minnesota 55431 Phone: (952) 888-4677 | |
Bloomington Drug Type: Community/Retail Pharmacy Location: 509 W 98th St, Bloomington, Minnesota 55420 Phone: (952) 884-7528 | |
Cub Pharmacy #1931 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 500 W 84th St, Bloomington, Minnesota 55420 Phone: (952) 346-8625 | |
Cub Pharmacy #1950/790 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 10520 France S Ave, Bloomington, Minnesota 55431 Phone: (952) 888-4310 |